Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
The Lancet. Oncology
|
April 13, 2023
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
Sandro Pignata, Giovanni Scambia, Clorinda Schettino, et al.
International Journal of Medical Sciences
|
April 16, 2021
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial
Eriseld Krasniqi, Laura Pizzuti, Maria Rosaria Valerio, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 12, 2021
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors
Alessandro Orsini, Thomas Foiadelli, Mariasole Magistrali, et al.
Cephalalgia : an International Journal of Headache
|
June 22, 2023
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study
Umberto Raucci, Pasquale Parisi, Valentina Ferro, et al.
Oncotarget
|
September 17, 2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
Patrizia Vici, Laura Pizzuti, Andrea Michelotti, et al.
Frontiers in Pediatrics
|
May 23, 2022
Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort
Chiara Po', Margherita Nosadini, Marialuisa Zedde, et al.
Cancers
|
December 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Journal of Cellular Physiology
|
December 12, 2018
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience
Laura Pizzuti, Antonio Giordano, Andrea Michelotti, et al.
Frontiers in Oncology
|
June 1, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from <i>CaRe</i>, a multicentric, observational study
Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, et al.
International Journal of Cancer
|
July 23, 2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting
Laura Pizzuti, Eriseld Krasniqi, Giacomo Barchiesi, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
The Lancet. Oncology
|
April 13, 2023
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
Sandro Pignata, Giovanni Scambia, Clorinda Schettino, et al.
International Journal of Medical Sciences
|
April 16, 2021
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial
Eriseld Krasniqi, Laura Pizzuti, Maria Rosaria Valerio, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
November 12, 2021
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors
Alessandro Orsini, Thomas Foiadelli, Mariasole Magistrali, et al.
Cephalalgia : an International Journal of Headache
|
June 22, 2023
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study
Umberto Raucci, Pasquale Parisi, Valentina Ferro, et al.
Oncotarget
|
September 17, 2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
Patrizia Vici, Laura Pizzuti, Andrea Michelotti, et al.
Frontiers in Pediatrics
|
May 23, 2022
Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort
Chiara Po', Margherita Nosadini, Marialuisa Zedde, et al.
Cancers
|
December 17, 2024
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study
Eriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Journal of Cellular Physiology
|
December 12, 2018
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience
Laura Pizzuti, Antonio Giordano, Andrea Michelotti, et al.
Frontiers in Oncology
|
June 1, 2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from <i>CaRe</i>, a multicentric, observational study
Francesca Sofia Di Lisa, Eriseld Krasniqi, Laura Pizzuti, et al.
International Journal of Cancer
|
July 23, 2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting
Laura Pizzuti, Eriseld Krasniqi, Giacomo Barchiesi, et al.
Page
of 7